Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Herpes Zoster Vaccine | 4 | 2021 | 112 | 1.74 | Why? |
| Bacterial Vaccines | 2 | 2017 | 139 | 1.25 | Why? |
| Papillomavirus Vaccines | 4 | 2018 | 405 | 1.20 | Why? |
| Chickenpox Vaccine | 3 | 2019 | 59 | 1.02 | Why? |
| Australia | 27 | 2021 | 6306 | 0.98 | Why? |
| Papillomavirus Infections | 4 | 2018 | 861 | 0.94 | Why? |
| Herpes Zoster | 4 | 2021 | 331 | 0.87 | Why? |
| Seizures, Febrile | 2 | 2019 | 59 | 0.86 | Why? |
| Influenza Vaccines | 7 | 2021 | 2941 | 0.80 | Why? |
| Vaccination | 20 | 2021 | 19050 | 0.78 | Why? |
| Watchful Waiting | 1 | 2021 | 276 | 0.75 | Why? |
| Chickenpox | 2 | 2019 | 194 | 0.74 | Why? |
| Varicella Zoster Virus Infection | 2 | 2018 | 40 | 0.73 | Why? |
| Measles-Mumps-Rubella Vaccine | 2 | 2019 | 282 | 0.69 | Why? |
| Acute Febrile Encephalopathy | 1 | 2017 | 27 | 0.69 | Why? |
| Paraplegia | 1 | 2017 | 38 | 0.68 | Why? |
| Mumps | 1 | 2019 | 110 | 0.68 | Why? |
| Rubella | 1 | 2019 | 127 | 0.67 | Why? |
| Transplantation, Autologous | 1 | 2018 | 364 | 0.65 | Why? |
| Injection Site Reaction | 1 | 2017 | 124 | 0.63 | Why? |
| Intussusception | 1 | 2017 | 102 | 0.62 | Why? |
| School Health Services | 1 | 2020 | 294 | 0.62 | Why? |
| Whooping Cough | 2 | 2018 | 201 | 0.61 | Why? |
| Influenza, Human | 13 | 2021 | 10779 | 0.58 | Why? |
| Immunization | 3 | 2018 | 2019 | 0.54 | Why? |
| Vomiting | 1 | 2017 | 722 | 0.47 | Why? |
| Measles | 1 | 2019 | 608 | 0.44 | Why? |
| Exanthema | 2 | 2018 | 1097 | 0.36 | Why? |
| Viral Vaccines | 3 | 2020 | 7560 | 0.35 | Why? |
| Immunization Programs | 6 | 2020 | 2006 | 0.35 | Why? |
| Headache | 1 | 2017 | 2257 | 0.32 | Why? |
| Respiratory Tract Infections | 3 | 2021 | 6817 | 0.30 | Why? |
| Child, Preschool | 18 | 2021 | 36283 | 0.29 | Why? |
| Uterine Cervical Neoplasms | 3 | 2018 | 842 | 0.29 | Why? |
| Child | 23 | 2021 | 70012 | 0.27 | Why? |
| Fever | 3 | 2018 | 7795 | 0.27 | Why? |
| Adverse Drug Reaction Reporting Systems | 3 | 2017 | 694 | 0.26 | Why? |
| Infant | 17 | 2021 | 30274 | 0.26 | Why? |
| Encephalitis, Viral | 2 | 2017 | 355 | 0.25 | Why? |
| Disease Notification | 2 | 2020 | 639 | 0.25 | Why? |
| Immunization Schedule | 2 | 2021 | 1305 | 0.23 | Why? |
| Disease Transmission, Infectious | 3 | 2021 | 9044 | 0.22 | Why? |
| Population | 1 | 2020 | 114 | 0.21 | Why? |
| Vaccines | 4 | 2020 | 3692 | 0.20 | Why? |
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2018 | 31 | 0.19 | Why? |
| Parechovirus | 1 | 2018 | 48 | 0.18 | Why? |
| Neopterin | 1 | 2018 | 69 | 0.18 | Why? |
| Schools | 4 | 2021 | 4187 | 0.18 | Why? |
| Antipyretics | 1 | 2018 | 107 | 0.18 | Why? |
| Vaccines, Combined | 1 | 2017 | 67 | 0.17 | Why? |
| Public Health Surveillance | 4 | 2020 | 3129 | 0.17 | Why? |
| Pharmacovigilance | 1 | 2021 | 501 | 0.16 | Why? |
| Herpesvirus 3, Human | 1 | 2019 | 228 | 0.16 | Why? |
| Adolescent | 16 | 2021 | 86841 | 0.16 | Why? |
| Communicable Disease Control | 3 | 2020 | 29620 | 0.16 | Why? |
| Brain Diseases | 2 | 2018 | 1463 | 0.15 | Why? |
| Hepatitis B Vaccines | 1 | 2018 | 245 | 0.15 | Why? |
| Pharmacies | 1 | 2020 | 356 | 0.15 | Why? |
| Transplantation, Homologous | 1 | 2018 | 757 | 0.14 | Why? |
| Pharmaceutical Services | 1 | 2020 | 347 | 0.14 | Why? |
| Product Surveillance, Postmarketing | 1 | 2017 | 189 | 0.14 | Why? |
| Humans | 42 | 2021 | 930598 | 0.14 | Why? |
| Papillomaviridae | 1 | 2018 | 404 | 0.13 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.13 | Why? |
| Population Surveillance | 3 | 2020 | 4967 | 0.13 | Why? |
| Seasons | 4 | 2020 | 4071 | 0.13 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2020 | 846 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.13 | Why? |
| Text Messaging | 1 | 2017 | 389 | 0.12 | Why? |
| Vaccination Coverage | 2 | 2019 | 1249 | 0.12 | Why? |
| Picornaviridae Infections | 1 | 2018 | 544 | 0.12 | Why? |
| Social Behavior | 1 | 2021 | 882 | 0.12 | Why? |
| Encephalitis | 1 | 2020 | 797 | 0.12 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.11 | Why? |
| Female | 20 | 2021 | 380317 | 0.11 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.11 | Why? |
| Child Health | 1 | 2020 | 940 | 0.11 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.11 | Why? |
| Primary Prevention | 1 | 2018 | 778 | 0.11 | Why? |
| Urban Population | 1 | 2021 | 2000 | 0.11 | Why? |
| Male | 20 | 2021 | 367725 | 0.10 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.10 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 877 | 0.10 | Why? |
| Infant, Newborn | 6 | 2021 | 23105 | 0.10 | Why? |
| Hepatitis B | 1 | 2018 | 888 | 0.10 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.10 | Why? |
| Health Surveys | 1 | 2021 | 2841 | 0.10 | Why? |
| Hospitals, Pediatric | 1 | 2020 | 1792 | 0.10 | Why? |
| England | 1 | 2021 | 5116 | 0.09 | Why? |
| Victoria | 2 | 2021 | 607 | 0.09 | Why? |
| Communicable Diseases | 2 | 2020 | 2148 | 0.09 | Why? |
| Canada | 2 | 2020 | 6018 | 0.08 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 1261 | 0.08 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.08 | Why? |
| Sentinel Surveillance | 3 | 2020 | 1093 | 0.08 | Why? |
| Hospitalization | 6 | 2020 | 54280 | 0.08 | Why? |
| Risk | 1 | 2018 | 5288 | 0.07 | Why? |
| Universities | 1 | 2021 | 4374 | 0.07 | Why? |
| Parents | 1 | 2019 | 2758 | 0.07 | Why? |
| Meningoencephalitis | 2 | 2018 | 208 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Immunocompromised Host | 2 | 2019 | 5150 | 0.07 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.07 | Why? |
| Aged | 9 | 2021 | 215776 | 0.07 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 2426 | 0.07 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.06 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.06 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.06 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Immunogenicity, Vaccine | 1 | 2018 | 4624 | 0.06 | Why? |
| National Health Programs | 2 | 2020 | 807 | 0.06 | Why? |
| Severity of Illness Index | 3 | 2019 | 48226 | 0.06 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.06 | Why? |
| Pregnancy | 2 | 2021 | 23879 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Education, Distance | 1 | 2020 | 4956 | 0.05 | Why? |
| Adult | 8 | 2021 | 244371 | 0.05 | Why? |
| Neuralgia, Postherpetic | 1 | 2018 | 22 | 0.05 | Why? |
| Contraindications, Procedure | 1 | 2018 | 161 | 0.04 | Why? |
| Health Services, Indigenous | 1 | 2019 | 178 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.04 | Why? |
| Acyclovir | 1 | 2018 | 154 | 0.04 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Electronic Mail | 1 | 2017 | 102 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| New South Wales | 1 | 2018 | 336 | 0.04 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 552 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.04 | Why? |
| Child, Hospitalized | 1 | 2019 | 556 | 0.04 | Why? |
| Meningococcal Infections | 1 | 2018 | 216 | 0.03 | Why? |
| Data Accuracy | 1 | 2020 | 715 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.03 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.03 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.03 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2018 | 1562 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| History, 21st Century | 1 | 2017 | 1849 | 0.03 | Why? |
| Program Evaluation | 1 | 2018 | 1929 | 0.03 | Why? |
| Pharmacists | 1 | 2020 | 1246 | 0.02 | Why? |
| Seizures | 1 | 2018 | 1163 | 0.02 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.02 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.02 | Why? |
| Heart Arrest | 1 | 2018 | 1239 | 0.02 | Why? |
| Electronic Health Records | 1 | 2020 | 3492 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.02 | Why? |
| Caregivers | 1 | 2019 | 3112 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Models, Statistical | 1 | 2021 | 5312 | 0.02 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.01 | Why? |
| Brain | 1 | 2017 | 5133 | 0.01 | Why? |
| Disease Outbreaks | 2 | 2019 | 27595 | 0.01 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 8811 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.01 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.00 | Why? |
Macartney's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(98)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_